Trials / Completed
CompletedNCT03352102
Electrical Stimulation of the Quadriceps and Diaphragm in Critically Ill Patients
Effects of Neuromuscular Electrical Stimulation of the Quadriceps and Diaphragm in Critically Ill Patients: a Pilot Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Pericles Almeida Delfino Duarte · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Subjects in MV will be included, divided into 3 groups: (a) Control Group (CG), (b) Stimulation of Quadriceps (Quadriceps Group - QG), (c) Stimulation of Diaphragm (Diaphragm Group - DG). The QG and DG patients will receive consecutive daily electrical stimulation sessions at specific points from the first day of randomization until ICU discharge. Respiratory and peripheral muscle strength, MV time, length of hospitalization and functional independence score (the Functional Status Score-ICU) will be recorded.
Detailed description
Objective: Evaluate the effectiveness of the Neuro Muscular Electrical Stimulation therapy in quadriceps versus diaphragm subjects on mechanical ventilation (MV). Subjects in MV will be included, divided into 3 groups: (a) Control Group (CG), (b) Stimulation of Quadriceps (Quadriceps Group - QG), (c) Stimulation of Diaphragm (Diaphragm Group - DG). The QG and DG patients will receive consecutive daily electrical stimulation sessions at specific points from the first day of randomization until ICU discharge. Respiratory and peripheral muscle strength, MV time, length of hospitalization and functional independence score (the Functional Status Score-ICU) will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electrical stimulation | Neuromuscular electrical stimulation therapy was performed |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-09-30
- Completion
- 2016-07-01
- First posted
- 2017-11-24
- Last updated
- 2017-12-05
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03352102. Inclusion in this directory is not an endorsement.